News

A publication by scientists of the Anticancer Fund

On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients

Ciska Verbaanderd, Ilse Rooman, Lydie Meheus, Isabelle Huys - On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients. Frontiers in Pharmacology, 31 January 2020, DOI: 10.3389/fphar.2019.01664

Transparancy of clinical trial reports assured

Clinical trials should remain transparent

A publication by scientists of the Anticancer Fund

Biased by design? Clinical trials and patient benefit in oncology

Pan Pantziarka, Ciska Verbaanderd, Lydie Meheus - Biased by design? Clinical trials and patient benefit in oncology. Future Medicine, 16 (3), doi.org/10.2217/fon-2019-0763

Patient and health systems opportunities

Bertolini, F., Sukhatme, V.P., & Bouche, G. (2015). Drug repurposing in oncology—patient and health systems opportunities. Nature Reviews Clinical Oncology, 12(12):732-42. doi:10.1038/nrclinonc.2015.169

ReDO: nitroglycerin as an anti-cancer agent

Sukhatme, V., Bouche, G., Meheus, L., Sukhatme, V. P., & Pantziarka, P. (2015). Repurposing Drugs in Oncology (ReDO)-nitroglycerin as an anti-cancer agent. Ecancermedicalscience, 9, 568. doi:10.3332/ecancer.2015.568